Understanding the Evidence Supporting the use of Dietary and Behavioral Therapies for IBS

Content Type: presentation

Presenter: Speakers: Peter Gibson, MD, Kate Scarlata, MPH, RDN, Megan E. Riehl, PsyD, William D. Chey, MD, FACG; Moderator: William D. Chey, MD, FACG

Presenter Disclosure: Peter Gibson, MD : Monash University financially benefits from the sales of digital applications, educational courses and literature related to the FODMAP diet. He has published one educational/recipe book on the FODMAP diet; Kate Scarlata, MPH, RDN : FODY food company (equity and consulting fees) Epicured (employee and equity); Gastro Girl, Inc., a co-parent owner of GI OnDEMAND, (equity and advisory fees); Megan E. Riehl, PsyD : Gastro Girl, Inc., a co-parent owner of GI OnDEMAND, (equity and advisory fees); Consultant for Health Union, LLC; William D. Chey, MD, FACG : Board of Directors and stock options of Gastro Girl, Inc. ( a co-parent owner of GI OnDEMAND)

Event: ACG Virtual Grand Rounds

Release Date: 7/24/2020

Expiration Date: 7/24/2023

Objective: Identify the evidence supporting the use of dietary and behavioral therapies for IBS, describe appropriate referrals to a GI dietitian, explain inappropriate referrals to a GI psychologist, and discuss the benefits of integrated care vs. traditional care for patients with digestive disorders.